- $103.11m
- $76.11m
- $240.68m
- 48
- 99
- 13
- 52
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-Q | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7.7 | 17.6 | 14.1 | 12.9 | 11.8 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Insurance Receivables | |||||
Long Term Notes Receivable | |||||
Deferred Policy Acquisition Costs | |||||
Total Other Assets | |||||
Total Assets | 1,745 | 1,843 | 1,855 | 1,591 | 1,669 |
Accrued Expenses | |||||
Policy Liabilities | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,485 | 1,542 | 1,534 | 1,463 | 1,497 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 260 | 301 | 321 | 128 | 172 |
Total Liabilities & Shareholders' Equity | 1,745 | 1,843 | 1,855 | 1,591 | 1,669 |
Total Common Shares Outstanding |